Skip links

Abilify MyCite® (aripiprazole tablets with sensor)

Full Name Abilify MyCite® (aripiprazole tablets with sensor)
Drug Abilify MyCite
Manufacturer Otsuka Pharmaceutical Co., Ltd.
Route of Administration Oral
Site of Care Home
Approved Indication Treatment of adults with schizophrenia, bipolar I disorder, and adjunctive treatment of adults with major depressive disorder (MDD)
Disease Schizophrenia; Bipolar Disorder; Major Depressive Disorder (MDD)
Therapeutic Area Psychiatry, Mental Health & Addiction
Enrollment Form Link Enrollment Form
Phone Number 844-692-4833
Fax Number 847-789-9274
Product Website